These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 33837554)

  • 81. Database size and power to detect safety signals in pharmacovigilance.
    Hammond IW; Gibbs TG; Seifert HA; Rich DS
    Expert Opin Drug Saf; 2007 Nov; 6(6):713-21. PubMed ID: 17967160
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Safety Profile of Sclerosing Agents: An Analysis From the World Health Organization Pharmacovigilance Database VigiBase.
    Roselli A; Khouri C; Roustit M; Blaise S; Cracowski JL
    Dermatol Surg; 2019 Dec; 45(12):1517-1528. PubMed ID: 30829775
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol.
    Nguyen KA; Mimouni Y; Jaberi E; Paret N; Boussaha I; Vial T; Jacqz-Aigrain E; Alberti C; Guittard L; Remontet L; Roche L; Bossard N; Kassai B
    Therapie; 2021; 76(6):675-685. PubMed ID: 33593598
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Suspected adverse reactions reported for blood, blood components, and blood products in VigiBase.
    Samukange WT; Lu TA; Souverein PC; Gardarsdottir H; Mantel-Teeuwisse AK
    Transfusion; 2023 May; 63(5):982-992. PubMed ID: 36994873
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study.
    Caldeira D; Rodrigues R; Abreu D; Anes AM; Rosa MM; Ferreira JJ
    Expert Opin Drug Saf; 2018 Apr; 17(4):339-345. PubMed ID: 29463153
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pharmacodynamic and pharmacokinetic drug interactions reported to VigiBase, the WHO global individual case safety report database.
    Strandell J; Wahlin S
    Eur J Clin Pharmacol; 2011 Jun; 67(6):633-41. PubMed ID: 21253716
    [TBL] [Abstract][Full Text] [Related]  

  • 87. SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database.
    Ado Moumouni AN; Robin P; Hillaire-Buys D; Faillie JL
    Fundam Clin Pharmacol; 2018 Apr; 32(2):216-226. PubMed ID: 29144574
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Safety profile of H1-antihistamines in pediatrics: an analysis based on data from VigiBase.
    Motola D; Donati M; Biagi C; Calamelli E; Cipriani F; Melis M; Monaco L; Vaccheri A; Ricci G
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1164-1171. PubMed ID: 28653802
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The value of patient reporting to the pharmacovigilance system: a systematic review.
    Inácio P; Cavaco A; Airaksinen M
    Br J Clin Pharmacol; 2017 Feb; 83(2):227-246. PubMed ID: 27558545
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Drug-induced tumoral disease: A global pharmacovigilance database analysis.
    Zelmat Y; Despas F
    Therapie; 2024; 79(2):189-197. PubMed ID: 38042752
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Adverse drug reaction reports for cardiometabolic drugs from sub-Saharan Africa: a study in VigiBase.
    Berhe DF; Juhlin K; Star K; Beyene KG; Dheda M; Haaijer-Ruskamp FM; Taxis K; Mol PG
    Trop Med Int Health; 2015 Jun; 20(6):797-806. PubMed ID: 25704305
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database.
    Cazacu I; Stroe R; Dondera R; Mogosan C; Haramburu F; Fourrier-Réglat A; Loghin F
    Fundam Clin Pharmacol; 2018 Jun; 32(3):330-336. PubMed ID: 29314262
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Drug interactions with apixaban: A systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports.
    Fernandez S; Lenoir C; Samer C; Rollason V
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00647. PubMed ID: 32881416
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Drug interactions related to self-medication: a French pharmacovigilance database study.
    Vacher R; Lagarce L; Ghamrawi S; Laugier-Castellan D; Vial T; Bagheri H; Babin M; Briet M
    Fundam Clin Pharmacol; 2020 Oct; 34(5):623-631. PubMed ID: 32064672
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database.
    Noseda R; Bedussi F; Gobbi C; Zecca C; Ceschi A
    Cephalalgia; 2021 Jun; 41(7):789-798. PubMed ID: 33435709
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study.
    Bretagne M; Lebrun-Vignes B; Pariente A; Shaffer CM; Malouf GG; Dureau P; Potey C; Funck-Brentano C; Roden DM; Moslehi JJ; Salem JE
    Arch Cardiovasc Dis; 2020 Jan; 113(1):9-21. PubMed ID: 31685432
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Thirst and drugs: A study in the World Health Organization's pharmacovigilance database.
    Montastruc JL
    Br J Clin Pharmacol; 2024 Jun; 90(6):1525-1528. PubMed ID: 38627211
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Drug-induced tics: An observational postmarketing study.
    Touafchia D; Montastruc F; Lapeyre-Mestre M; Rousseau V; Chebane L; Revet A
    Hum Psychopharmacol; 2020 Jul; 35(4):e2734. PubMed ID: 32352603
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
    Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
    J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Adverse drug reactions to self-medication: a study in a pharmacovigilance database.
    Berreni A; Montastruc F; Bondon-Guitton E; Rousseau V; Abadie D; Durrieu G; Chebane L; Giroud JP; Bagheri H; Montastruc JL
    Fundam Clin Pharmacol; 2015 Oct; 29(5):517-20. PubMed ID: 26215671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.